-
L126699-1gLaquinimod is a potent immunomodulator. Phase 3.
-
L126699-250mgLaquinimod is a potent immunomodulator. Phase 3.
-
L126699-50mgLaquinimod is a potent immunomodulator. Phase 3.
-
L125568-10mgLaropiprant(MK 0524) is a potent, selective DP1 receptor antagonist with Ki value of 0.57 nM: exhibits >:1,000 fold selectivity over DP2 receptor (Ki=0.75 uM).
-
L125568-50mgLaropiprant(MK 0524) is a potent, selective DP1 receptor antagonist with Ki value of 0.57 nM: exhibits >:1,000 fold selectivity over DP2 receptor (Ki=0.75 uM).
-
L125568-5mgLaropiprant(MK 0524) is a potent, selective DP1 receptor antagonist with Ki value of 0.57 nM: exhibits >:1,000 fold selectivity over DP2 receptor (Ki=0.75 uM).
-
L172696-100mgLarotrectinibFor.
-
L172696-10mgLarotrectinibFor.
-
L172696-25mgLarotrectinibFor.
-
L172696-50mgLarotrectinibFor.
-
L172696-5mgLarotrectinibFor.
-
L420963-1mlLarotrectinibFor.